About OncoRes Medical
OncoRes Medical is developing an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumour and healthy tissue . The technology under development utilises a novel combination of optical coherence tomography imaging and elastography to provide a rapid evaluation of tissue microarchitecture at a scale and resolution comparable to histology. The Company’s initial focus is on the development of an imaging probe that will enable breast cancer surgeons to identify residual cancer following the excision of the tumour, providing a solution to address the high re-excision rates for breast cancer patients. OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leading researchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system. With funding provided by the Medical Research Commercialisation Fund (MRCF) , OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.